AURA: Aura Biosciences Company Cash Volume

AURA (Aura Biosciences) - company brandmark

Cash reserve dynamics demonstrate that the metric level stands at 0.30. Aura Biosciences, Inc. (AURA) relies on strict temperature control during the delivery of drugs to clinics to maintain business efficiency. Unique laser particles that preserve patient vision drive high demand. Meanwhile, the company's environmental policy is limited to the safe disposal of chemical waste in research laboratories.

Company Cash Reserve: Aura Bio (AURA) for 07/04/2022 - 11/22/2026

Metric breakdowns and analytics for Aura Biosciences (AURA)

Basic company analysis:Aura Biosciences Inc
Brand item of aurabiosciences.com

For Aura Biosciences, Inc. (AURA), which develops targeted cancer therapies, liquidity levels dictate the pace of innovation commercialization. This metric measures available cash reserves, allowing for an assessment of financial stability and default risk while excluding illiquid assets. By analyzing current cash levels, an investor compares capital against industry benchmarks to identify resource surpluses or deficits. This is critical for expanding the patient base upon the approval of new products.

Competitors of Aura Biosciences, Inc. (AURA)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds